Eunmi Nam

1.7k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Eunmi Nam is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Eunmi Nam has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Surgery. Recurrent topics in Eunmi Nam's work include Gastric Cancer Management and Outcomes (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Eunmi Nam is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Eunmi Nam collaborates with scholars based in South Korea, Germany and United States. Eunmi Nam's co-authors include Se Hoon Park, Dong Bok Shin, Sung Yong Oh, Keon Woo Park, Hyuk‐Chan Kwon, Jeeyun Lee, Joon Oh Park, In Gyu Hwang, Do Hyoung Lim and Sang‐Cheol Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Eunmi Nam

30 papers receiving 1.1k citations

Hit Papers

Salvage Chemotherapy for Pretreated Gastric Cancer: A Ran... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
    2012 474 citations Jung Hun Kang, Soon Il Lee et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eunmi Nam South Korea 15 660 513 295 193 192 30 1.1k
Ricardo Cubedo Spain 14 637 1.0× 566 1.1× 223 0.8× 42 0.2× 196 1.0× 50 1.1k
Mesut Şeker Türkiye 17 488 0.7× 615 1.2× 410 1.4× 147 0.8× 92 0.5× 98 1.3k
Yasser Khafaga Saudi Arabia 20 300 0.5× 454 0.9× 312 1.1× 101 0.5× 46 0.2× 49 1.3k
Renata D’Alpino Peixoto Brazil 17 320 0.5× 569 1.1× 295 1.0× 221 1.1× 63 0.3× 95 964
Seong Yoon Yi South Korea 22 466 0.7× 487 0.9× 301 1.0× 88 0.5× 48 0.3× 70 1.2k
Franco Uggeri Italy 21 450 0.7× 477 0.9× 649 2.2× 164 0.8× 74 0.4× 61 1.2k
Amyn Haji United Kingdom 19 388 0.6× 611 1.2× 645 2.2× 135 0.7× 148 0.8× 77 1.2k
Katsunari Takifuji Japan 21 528 0.8× 551 1.1× 716 2.4× 70 0.4× 241 1.3× 98 1.3k
Bala Başak Öven Ustaalıoğlu Türkiye 16 433 0.7× 523 1.0× 365 1.2× 121 0.6× 110 0.6× 83 1.1k
Boram Han South Korea 17 342 0.5× 334 0.7× 160 0.5× 76 0.4× 62 0.3× 56 877

Countries citing papers authored by Eunmi Nam

Since Specialization
Citations

This map shows the geographic impact of Eunmi Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunmi Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunmi Nam more than expected).

Fields of papers citing papers by Eunmi Nam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eunmi Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunmi Nam. The network helps show where Eunmi Nam may publish in the future.

Co-authorship network of co-authors of Eunmi Nam

This figure shows the co-authorship network connecting the top 25 collaborators of Eunmi Nam. A scholar is included among the top collaborators of Eunmi Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eunmi Nam. Eunmi Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiovitz, Stacey, Monica M. Bertagnolli, Lindsay A. Renfro, et al.. (2014). CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer. Gastroenterology. 147(3). 637–645. 104 indexed citations
2.
Kang, Jung Hun, Soon Il Lee, Do Hyoung Lim, et al.. (2012). Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone. Journal of Clinical Oncology. 30(13). 1513–1518. 474 indexed citations breakdown →
3.
Park, Se Hoon, Young Saing Kim, Junshik Hong, et al.. (2008). Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. Anti-Cancer Drugs. 19(3). 303–307. 25 indexed citations
4.
Park, Se Hoon, Young Saing Kim, Junshik Hong, et al.. (2008). Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research. 17(2). 207–214. 43 indexed citations
5.
Park, Se Hoon, Soo‐Mee Bang, Eunmi Nam, et al.. (2008). A Randomized Double-Blind Placebo-Controlled Study of Low-Dose Intravenous Lorazepam to Reduce Procedural Pain During Bone Marrow Aspiration and Biopsy. Pain Medicine. 9(2). 249–252. 32 indexed citations
6.
Dittrich, Ralf, Stephan P. Kloska, Tobias Fischer, et al.. (2008). Accuracy of perfusion-CT inpredicting malignant middle cerebral artery brain infarction. Journal of Neurology. 255(6). 896–902. 31 indexed citations
7.
Nabavi, Darius G., Ralf Dittrich, Stephan P. Kloska, et al.. (2007). Window narrowing: a new method for standardized assessment of the tissue at risk-maximum of infarction in CT based brain perfusion maps. Neurological Research. 29(3). 296–303. 6 indexed citations
8.
9.
Kong, Jee Hyun, Seung-Hyun Yoo, Kyoung Eun Lee, et al.. (2007). Early Imatinib Mesylate-Induced Hepatotoxicity in Chronic Myelogenous Leukaemia. Acta Haematologica. 118(4). 205–208. 27 indexed citations
10.
Park, Se Hoon, Eunmi Nam, Soo‐Mee Bang, et al.. (2007). A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 62(1). 1–9. 10 indexed citations
11.
Oh, Sung Yong, Hyuk‐Chan Kwon, Won Seog Kim, et al.. (2007). Intestinal marginal zone B‐cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease. European Journal Of Haematology. 79(4). 287–291. 10 indexed citations
12.
Hong, Junshik, Se Hoon Park, Soo Jin Na Choi, et al.. (2007). Nail Toxicity after Treatment with Docetaxel: A Prospective Analysis in Patients with Advanced Non-small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 37(6). 424–428. 21 indexed citations
13.
Park, Se Hoon, Kwang Il Ko, Eunmi Nam, et al.. (2006). A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer. Cancer Research and Treatment. 38(3). 121–121. 1 indexed citations
14.
Oh, Sung Yong, Won Seog Kim, Baek‐Yeol Ryoo, et al.. (2006). Intestinal Marginal Zone B-Cell Lymphoma of MALT Type: Clinical Manifestation and Outcome of a Rare Disease.. Blood. 108(11). 4742–4742. 1 indexed citations
15.
Kloska, Stephan P., Darius G. Nabavi, Eunmi Nam, et al.. (2004). Acute Stroke Assessment with CT: Do We Need Multimodal Evaluation?. Radiology. 233(1). 79–86. 92 indexed citations
16.
Lee, Seung‐Hoon, Jinny Park, Se Hoon Park, et al.. (2004). Capecitabine Monotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer. Medical Oncology. 21(3). 223–232. 31 indexed citations
17.
Im, Sun, et al.. (2004). Expression of cyclooxygenase-2 in Korean breast cancer patients and the in vitro growth inhibitory effect of celecoxib in breast cancer cells. Journal of Clinical Oncology. 22(14_suppl). 9715–9715. 1 indexed citations
18.
Park, Jinny, Se‐Hoon Lee, Se Hoon Park, et al.. (2003). P-620 Gefitinib (‘Iressa’, ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small-cell lung cancer (NSCLC). Lung Cancer. 41. S249–S249. 8 indexed citations
19.
20.
Kım, Kihyun, Eunmi Nam, Nam Soo Lee, et al.. (2002). Oxaliplatin and UFT Combination Chemotherapy in Patients With Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 25(4). 354–357. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Cubedo Breakdown of academic impact, for papers by Mesut Şeker Breakdown of academic impact, for papers by Yasser Khafaga Breakdown of academic impact, for papers by Renata D’Alpino Peixoto Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by Franco Uggeri Breakdown of academic impact, for papers by Amyn Haji Breakdown of academic impact, for papers by Katsunari Takifuji Breakdown of academic impact, for papers by Bala Başak Öven Ustaalıoğlu Breakdown of academic impact, for papers by Boram Han
Rankless by CCL
2026